ICMR reviewing use of tocilizumab for treatment of coronavirus pandemic

Tocilizumab is a rheumatoid arthritis drug manufactured by Swiss pharmaceutical company Roche under the brand name Actemra. The medication is part of the health ministry ’s clinical management protocol for Covid-19 under investigational therapies for patients with moderate symptoms of the illness.
Source: The Economic Times - Category: Consumer Health News Source Type: news